Private healthcare services network MedLife reported a pro-forma consolidated turnover of 222.1 million euros in H1 2023, up 27 percent year-over-year, of which 12 percent from organic growth, write Agerpres.
According to a company release, all the group’s business lines saw robust growth between January – June 2023, with clinics recording the best performance (+41 percent), followed by hospitals (+36 percent), the corporate division (+13 percent), dental clinics (+11 percent), and laboratories (+9 percent).
In terms of profitability, the group’s EBITDA margin dropped slightly from 15.8 percent in H1 2022 to 15.2 percent in H1 2023, but the Q2 vs. Q1 seasonal decrease was less pronounced in 2023 compared to the previous year. As far as the outlooks for the next period are concerned, MedLife focuses on strengthening its leading position by continuing organic projects with an emphasis on expanding the hospital network in Bucharest, by continuing work on the MedLife Park project and by opening new facilities in the region of Oltenia and in the western part of the country.
Currently, MedLife Group owns the largest network of private medical services in Romania, with around 700 own and partner locations nationwide. More than 6 million single patients have so far used the group’s own units’ prevention, wellness, treatment and hospitalization services, and more than 800,000 employees benefit from subscription medical services. MedLife SA shares are being traded on the regulated spot market administered by the Bucharest Stock Exchange, Premium category.
